These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 761443)

  • 1. Binding of imipramine to plasma proteins: effect of hyperlipoproteinemia.
    Danon A; Chen Z
    Clin Pharmacol Ther; 1979 Mar; 25(3):316-21. PubMed ID: 761443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma protein binding of imipramine in patients with rheumatoid arthritis.
    Kristensen CB
    Eur J Clin Pharmacol; 1985; 28(6):693-6. PubMed ID: 4065195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the binding of imipramine to erythrocytes and plasma proteins on its transport through the rat blood-brain barrier.
    Riant P; Urien S; Albengres E; Renouard A; Tillement JP
    J Neurochem; 1988 Aug; 51(2):421-5. PubMed ID: 3392536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure of human high density lipoprotein and the levels of apolipoprotein A-I in plasma as determined by radioimmunoassay.
    Schonfeld G; Pfleger B
    J Clin Invest; 1974 Aug; 54(2):236-46. PubMed ID: 4136225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipramine steady-state studies and plasma binding.
    Glassman AH; Hurwic MJ; Kanzler M; Shostak M; Perel JM
    Adv Biochem Psychopharmacol; 1974; 9(0):457-61. PubMed ID: 4836219
    [No Abstract]   [Full Text] [Related]  

  • 6. Binding of imipramine to plasma protein and to brain tissue: relationship to CSF tricyclic levels in man.
    Potter WZ; Muscettola G; Goodwin FK
    Psychopharmacology (Berl); 1979 May; 63(2):187-92. PubMed ID: 112637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of quinidine to plasma proteins in normal subjects and in patients with hyperlipoproteinemias.
    Kates RE; Sokoloski TD; Comstock TJ
    Clin Pharmacol Ther; 1978 Jan; 23(1):30-5. PubMed ID: 618708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of cancer on the serum protein binding to mianserin and imipramine.
    Torres I; Suárez E; Rodríguez-Sasiain JM; Aguirre C; Calvo R
    Eur J Drug Metab Pharmacokinet; 1995; 20(2):107-11. PubMed ID: 8582434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipramine serum protein binding in healthy subjects.
    Kristensen CB
    Clin Pharmacol Ther; 1983 Nov; 34(5):689-94. PubMed ID: 6627829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of lymphoproliferation by hyperlipoproteinemic plasma.
    Waddell CC; Taunton OD; Twomey JJ
    J Clin Invest; 1976 Oct; 58(4):950-4. PubMed ID: 184112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitors of reverse serotonin uptake and of specific imipramine binding in human blood plasma].
    Brusov OS; Lideman RR; Fomenko AM; Katasonov AB
    Biull Eksp Biol Med; 1985 Jul; 100(7):26-8. PubMed ID: 4016237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.
    Gianturco SH; Gotto AM; Jackson RL; Patsch JR; Sybers HD; Taunton OD; Yeshurun DL; Smith LC
    J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Typing of hyperlipoproteinemia in an Israel hospital.
    Eisenberg S
    Isr J Med Sci; 1976 Nov; 12(11):1261-8. PubMed ID: 1017927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lecithin:cholesterol acyl transfer rate in plasma and its relations to lipoprotein concentrations and to kinetics of bile acids and triglycerides in hyperlipoproteinemic subjects.
    Wallentin L; Angelin B; Einarsson K; Leijd B
    Scand J Clin Lab Invest Suppl; 1978; 150():103-10. PubMed ID: 218268
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma-protein binding of tricyclic antidepressants.
    Braithwaite RA
    Postgrad Med J; 1980; 56 Suppl 1():107-11. PubMed ID: 6994085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolism of very low density lipoprotein proteins. II. Studies on the transfer of apoproteins between plasma lipoproteins.
    Eisenberg S; Bilheimer DW; Levy RI
    Biochim Biophys Acta; 1972 Sep; 280(1):94-104. PubMed ID: 4341829
    [No Abstract]   [Full Text] [Related]  

  • 17. An approach to the management of hyperlipoproteinemia.
    Hoeg JM; Gregg RE; Brewer HB
    JAMA; 1986 Jan 24-31; 255(4):512-21. PubMed ID: 3510334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma binding of imipramine and clinical outcome.
    Glassman AH; Hurwic MJ; Perel JM
    Am J Psychiatry; 1973 Dec; 130(12):1367-9. PubMed ID: 4754681
    [No Abstract]   [Full Text] [Related]  

  • 19. Imipramine protein binding and pharmacokinetics in children.
    Winsberg BG; Perel JM; Hurwic MJ; Klutch A
    Adv Biochem Psychopharmacol; 1974; 9(0):425-31. PubMed ID: 4836217
    [No Abstract]   [Full Text] [Related]  

  • 20. Binding of thyroid hormones to human plasma lipoproteins.
    Benvenga S; Gregg RE; Robbins J
    J Clin Endocrinol Metab; 1988 Jul; 67(1):6-16. PubMed ID: 3379137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.